buserelin has been researched along with Adenoma, Chromophobe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beardwell, CG; Chapman, AJ; Dutton, J; MacFarlane, IA; Shalet, SM; Sutton, ML | 1 |
| Damjanović, S; Kendereski, A; Manojlović, D; Micić, D; Mićić, J; Petakov, M; Popović, V; Sumarac, M | 1 |
2 other study(ies) available for buserelin and Adenoma, Chromophobe
| Article | Year |
|---|---|
Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
Topics: Adenoma, Chromophobe; Bromocriptine; Buserelin; Dexamethasone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Middle Aged; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Thyroxine | 1984 |
Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
Topics: Adenoma, Chromophobe; Adult; Buserelin; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Testosterone | 1991 |